4.7 Review

Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy

期刊

出版社

MDPI
DOI: 10.3390/ijms23169341

关键词

anticancer therapy; cyclophilin A; CD147; PPIA; BSG

资金

  1. Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2021R1I1A3050093]
  2. Brain Korea 21 Project, Korea

向作者/读者索取更多资源

The interaction between Cyclophilin A and CD147 plays a crucial role in multiple diseases, particularly in the progression of cancer. Their overexpression is associated with cancer cell growth, metastasis, therapeutic resistance, and stem cell-like properties, leading to poor prognosis in cancer patients. Therefore, targeting the Cyclophilin A/CD147 interaction may improve treatment outcomes for cancer patients.
Cyclophilin A (CypA), which has peptidyl-prolyl cis-trans isomerase (PPIase) activity, regulates multiple functions of cells by binding to its extracellular receptor CD147. The CypA/CD147 interaction plays a crucial role in the progression of several diseases, including inflammatory diseases, coronavirus infection, and cancer, by activating CD147-mediated intracellular downstream signaling pathways. Many studies have identified CypA and CD147 as potential therapeutic targets for cancer. Their overexpression promotes growth, metastasis, therapeutic resistance, and the stem-like properties of cancer cells and is related to the poor prognosis of patients with cancer. This review aims to understand the biology and interaction of CypA and CD147 and to review the roles of the CypA/CD147 interaction in cancer pathology and the therapeutic potential of targeting the CypA/CD147 axis. To validate the clinical significance of the CypA/CD147 interaction, we analyzed the expression levels of PPIA and BSG genes encoding CypA and CD147, respectively, in a wide range of tumor types using The Cancer Genome Atlas (TCGA) database. We observed a significant association between PPIA/BSG overexpression and poor prognosis, such as a low survival rate and high cancer stage, in several tumor types. Furthermore, the expression of PPIA and BSG was positively correlated in many cancers. Therefore, this review supports the hypothesis that targeting the CypA/CD147 interaction may improve treatment outcomes for patients with cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据